ORAL FORMULATION
Oral formulations
Dosage formsCapsules · tablets · powders · beverages
GradeMitoIgnite® 99%
Validated combination: TI-3N® (urolithin A + fisetin + ergothioneine), supported by 56-day human efficacy data; composition PCT patent filing in progress.
TOPICAL FORMULATION
Topical formulations
80% powderUse level 0.1–1%
WS water-dispersible ≥10%Use level 1–5% · can be added directly to the water phase
Validated combination: LicorPure® + MitoYouth®, supported by human efficacy data after 4 weeks of use; the 34-subject study of the 0.1% cream is itself a formulation-level validation.
01
Formulation proposal
Define the target consumer, use occasion and dosage form; oral and topical routes in parallel, with combination recommendations and claim language for the target market
02
Lab-scale sampling
Solve dispersion and stability of a poorly water-soluble active in aqueous and solid systems, and deliver samples ready for trial
03
Formulation-level validation
Stability and stress testing, system compatibility, and formulation-level human efficacy evaluation
04
ODM production
When finished products are required, Taiyi Health's ODM system takes over: formulation, sampling, validation and mass production